These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


670 related items for PubMed ID: 24513184

  • 1. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.
    Sethi KK, Verma SM, Tanç M, Purper G, Calafato G, Carta F, Supuran CT.
    Bioorg Med Chem; 2014 Mar 01; 22(5):1586-95. PubMed ID: 24513184
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase inhibitors: Synthesis and inhibition of the cytosolic mammalian carbonic anhydrase isoforms I, II and VII with benzene sulfonamides incorporating 4,5,6,7-tetrachlorophthalimide moiety.
    Sethi KK, Verma SM, Tanç M, Carta F, Supuran CT.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5168-74. PubMed ID: 23867389
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
    Alafeefy AM, Abdel-Aziz HA, Vullo D, Al-Tamimi AM, Awaad AS, Mohamed MA, Capasso C, Supuran CT.
    J Enzyme Inhib Med Chem; 2015 Feb 01; 30(1):52-6. PubMed ID: 24666294
    [Abstract] [Full Text] [Related]

  • 6. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J, Sprudza A, Tanc M, Vozny I, Zalubovskis R, Tars K, Supuran CT.
    Bioorg Med Chem; 2013 Sep 01; 21(17):5130-8. PubMed ID: 23859774
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L, Fasolis G, Vullo D, Chohan ZH, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3096-101. PubMed ID: 15908204
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Ibrahim DA, Lasheen DS, Zaky MY, Ibrahim AW, Vullo D, Ceruso M, Supuran CT, Abou El Ella DA.
    Bioorg Med Chem; 2015 Aug 01; 23(15):4989-4999. PubMed ID: 26048024
    [Abstract] [Full Text] [Related]

  • 10. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS, Angapelly S, Angeli A, Digwal CS, Arifuddin M, Babu BN, Supuran CT, Kamal A.
    J Enzyme Inhib Med Chem; 2017 Dec 01; 32(1):1274-1281. PubMed ID: 28965419
    [Abstract] [Full Text] [Related]

  • 11. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
    Saluja AK, Tiwari M, Vullo D, Supuran CT.
    Bioorg Med Chem Lett; 2014 Mar 01; 24(5):1310-4. PubMed ID: 24507918
    [Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jan 01; 71():135-47. PubMed ID: 24291567
    [Abstract] [Full Text] [Related]

  • 13. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies.
    Carta F, Garaj V, Maresca A, Wagner J, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT.
    Bioorg Med Chem; 2011 May 15; 19(10):3105-19. PubMed ID: 21515057
    [Abstract] [Full Text] [Related]

  • 14. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
    Carradori S, Mollica A, Ceruso M, D'Ascenzio M, De Monte C, Chimenti P, Sabia R, Akdemir A, Supuran CT.
    Bioorg Med Chem; 2015 Jul 01; 23(13):2975-81. PubMed ID: 26007302
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2011 Oct 01; 21(19):5892-6. PubMed ID: 21852133
    [Abstract] [Full Text] [Related]

  • 17. Synthesis of novel acridine and bis acridine sulfonamides with effective inhibitory activity against the cytosolic carbonic anhydrase isoforms II and VII.
    Ulus R, Yeşildağ I, Tanç M, Bülbül M, Kaya M, Supuran CT.
    Bioorg Med Chem; 2013 Sep 15; 21(18):5799-805. PubMed ID: 23910989
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z, Sławiński J, Saczewski F, Innocenti A, Supuran CT.
    Eur J Med Chem; 2010 Jun 15; 45(6):2396-404. PubMed ID: 20202722
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.